Conditions: purity figure · SGN.
I would like help reading this properly rather than being told what conclusion to reach.
I have the full report including the method section, so I can quote specifics if that helps.
How should I read this, and where are the traps?
More usefully, the certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 5 Oct 2025 by kwn_analytical — removed a claim I could not source
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
Stated carefully, the test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Ask whether the certificate answers the question you are actually asking, because the answer is often no.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
The most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.
Reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.